Novartis AG (ADR) (NVS) Beats Analyst Estimates; Is Expected To Perform Well Backed By Recent Deals

In an interview with Bloomberg, Odile Rundquist, who is an analyst at Helvea, discusses on the second Qtr. results of the world’s largest drug maker by revenue, Novartis AG (ADR) (NYSE:NVS).

“I would say first that they do not really miss estimates. I mean they were a touch below by 1% on the topline and 1% on the bottom line. So I mean it is really a very small miss,” said Rundquist.

She added that we needed to focus now on the three key divisions of the company which will be part of the continuing business of Novartis AG (ADR) (NYSE:NVS) i.e. Pharmaceutical, Alcon and Sandoz.

Novartis AG (ADR) (NYSE:NVS)

On the deal between Novartis AG (ADR) (NYSE:NVS) and Google Inc. (NASDAQ:GOOGL), Rundquist said that the deal is interesting for both the companies and the deal represents a new way to thinking in healthcare, by combining bio-technology healthcare with technology.

The technology being a non-invasive way of measuring glucose, could give real-time monitoring and treatment in case of Diabetes, said Rundquist.

On 32% of sales for the company being from so-called ‘growth products,’ Rundquist feels that it is a good figure considering many new launches since 2009 which form part of this category. She added that investors need to look at the data on Phase III of LCZ 696 in the coming months, which is a new drug for chronic heart failure and can become a $5 billion drug for the company.

In another interview, Bloomberg’s Sam Fazeli, speaking on the recent results of Novartis AG (ADR) (NYSE:NVS), said that structural changes from various deals like the one with GlaxoSmithKline plc (ADR) (NYSE:GSK) & Eli Lilly and Co (NYSE:LLY), won’t be reflecting in the company’s group financials this year, as these deals will be closing by early next year.

Fazeli added that the deal with Google Inc. (NASDAQ:GOOGL) will help in bringing more innovation into Google’s latest technology in terms of the type of lenses and that they need to convince diabetes patients also that this technology is as high-quality and sensitive as other available technologies.

“What will you see with this company is that as it products, and most pharma companies, as their products switch to more specialty care products; to more oncology type products, where the prices are healthier and the costs of selling them are lower, certainly less than if you were selling to every corner shop GP, if you like, the reality is that that automatically brings down the selling and administrative costs,” Fazeli said on lowering of administrative costs.

Disclosure: none

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!